Furthermore, the KM plotter and GEPIA results demonstrated that when prostate cancer progresses, there are changes in the expression of CDH1, CDH2, VIM, SNAI1, ZEB1, and ZEB2. This evidence concerns the gene SNAI1 and prostate carcinoma.